Rapid Micro Biosystems, Inc. (RPID)

Market Cap	38.73M
Revenue (ttm)	26.17M
Net Income (ttm)	-48.40M
Shares Out	43.03M
EPS (ttm)	-1.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	115,607
Open	1.060
Previous Close	1.000
Day's Range	0.900 - 1.060
52-Week Range	0.580 - 1.340
Beta	1.06
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 1, 2024

About RPID

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial qu...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 15, 2021
• Employees: 193
• Stock Exchange: NASDAQ
• Ticker Symbol: RPID
• Website: https://www.rapidmicrobio.com

Financial Performance

In 2023, Rapid Micro Biosystems's revenue was $22.52 million, an increase of 31.44% compared to the previous year's $17.13 million. Losses were -$52.47 million, -13.71% less than in 2022.